本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

RENOVARO BIOSCIENCES INC

0.3359
+0.02648.53%
盘后0.33590.00000.00%19:12 EDT
成交量:63.22万
成交额:21.12万
市值:5,377.29万
市盈率:-0.41
高:0.3489
开:0.3300
低:0.3202
收:0.3095
数据加载中...
2024/01/24

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/01/24

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/01/24

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/01/24

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/01/24

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/01/24

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/01/16

重要事件披露

Form 8-K - Current report
2024/01/16

重要事件披露

Form 8-K - Current report
2023/12/01

重要事件披露

Form 8-K - Current report
2023/11/15

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/04

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/10/30

[修订]年度报告

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
2023/10/23

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/10/11

重要事件披露

Form 8-K - Current report
2023/10/11

重要事件披露

Form 8-K - Current report
2023/10/10

重要事件披露

Form 8-K - Current report
2023/10/07

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/10/06

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/10/02

重要事件披露

Form 8-K - Current report
2023/10/02

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]